Gilead paid $202 million and admitted conduct in HIV speaker-program kickback case
Company: Gilead Sciences, Inc.
Summary
Gilead agreed to pay $202 million in 2025 to settle claims that its HIV speaker programs provided kickbacks through honoraria, luxury meals and travel to induce prescriptions. Gilead made factual admissions concerning parts of the conduct, which ran from January 2011 through November 2017. Source: https://www.justice.gov/usao-sdny/pr/us-attorney-announces-202-million-settlement-gilead-sciences-using-speaker-programs